Biogen (BIIB) Minority Interest (2009 - 2023)

Biogen's Minority Interest history runs 15 years deep, the most recent figure standing at -$4.1 million for Q3 2023.

• In Q3 2023, Minority Interest rose 52.87% year-over-year to -$4.1 million; the TTM figure through Sep 2023 stood at -$4.1 million (up 52.87% YoY), while the FY2022 annual figure was -$9.5 million, down 114.96% from the prior year.
• Minority Interest was -$4.1 million for Q3 2023 at Biogen, up from -$6.4 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $462.9 million in Q2 2021 to a low of -$21.6 million in Q1 2022.
• Historically, Minority Interest has averaged $42.8 million across 5 years, with a median of -$8.7 million in 2022.
• The sharpest annual moves came in 2020 and 2021: Minority Interest tumbled 375.61% in 2020, then jumped 3327.14% in 2021.
• A 5-year view of Minority Interest shows it stood at -$4.1 million in 2019, then tumbled by 246.34% to -$14.2 million in 2020, then jumped by 547.18% to $63.5 million in 2021, then tumbled by 114.96% to -$9.5 million in 2022, then surged by 56.84% to -$4.1 million in 2023.
• The last three Minority Interest figures came in at -$4.1 million (Q3 2023), -$6.4 million (Q2 2023), and -$9.6 million (Q1 2023), per Business Quant data.